Form D · Pharmaceuticals
Esperion Therapeutics, Inc.
Ann Arbor, MI · CIK 0001434868
Offering snapshot reported Jul 15, 2014 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 30, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 15, 2014 | Initial | $0 | No comparison | 1 | SEC filing |
| Apr 26, 2013 | Initial | $17,000,000 | No comparison | 10 | SEC filing |
| Feb 11, 2011 | Amendment | $27,950,000 | $200,000vs Feb 12, 2010 | 9 | SEC filing |
| Feb 12, 2010 | Amendment | $27,750,000 | No comparison | 7 | SEC filing |
| May 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-221046
Issued a warrant to purchase common stock that is exercisable in connection with a Loan and Security Agreement. See Form 8-K filed with the SEC on July 2, 2014 for additional details.
Source: Form D, filed Jul 15, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alison De Bord | Director |
| Patrick Enright | Director |
| Dov A. Goldstein | Director |
| Antonio M. Gotto, Jr. | Director |
| Troy A. Ignelzi | Executive |
| Daniel Janney | Director |
| Alison Kiley | Director |
| Louis G. Lange | Director |
| Timothy M. Mayleben | Director |
| Tim M. Mayleben | Director, Executive |
| Mark E. Mc Govern | Director |
| Roger S. Newton | Director |
| Gilbert S. Omenn | Director |
| Noah L. Rosenberg | Executive |
| Nicole Vitullo | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3891 Ranchero Drive, Suite 150
Ann Arbor, MI, 48108
Ann Arbor, MI, 48108